Minivelle regulatory update

FDA approved an sNDA from Hisamitsu's Noven Pharmaceuticals Inc. subsidiary for Minivelle estradiol transdermal patch to prevent postmenopausal osteoporosis and for a new low dose. Minivelle is appro...